Breast cancer
- Cannabinoids and triple-negative breast cancer treatment (03 Sep 2024)
- Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors (02 Sep 2024)
- Cannabinoid Conference 2022 (27 Aug 2024)
- Modulation of breast cancer cell viability by a cannabinoid receptor 2 (18 Aug 2024)
- Effect of combining CBD with standard breast cancer therapeutics (31 Jul 2022)